Abstract
Our study provides the first evidence on site-specific Medicare spending on chemotherapy adjusting for patient comorbid illnesses, cancer type, and other cancer-related risks.
Original language | English (US) |
---|---|
Number of pages | 1 |
Journal | The American journal of managed care |
Volume | 24 |
Issue number | 10 |
State | Published - Oct 1 2018 |
All Science Journal Classification (ASJC) codes
- Health Policy